These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29674580)

  • 1. Parkin function in Parkinson's disease.
    Arkinson C; Walden H
    Science; 2018 Apr; 360(6386):267-268. PubMed ID: 29674580
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural analysis of the effects of mutations in Ubl domain of Parkin leading to Parkinson's disease.
    Biswas S; Roy R; Biswas R; Bagchi A
    Gene; 2020 Feb; 726():144186. PubMed ID: 31647998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoregulation of Parkin activity through its ubiquitin-like domain.
    Chaugule VK; Burchell L; Barber KR; Sidhu A; Leslie SJ; Shaw GS; Walden H
    EMBO J; 2011 Jun; 30(14):2853-67. PubMed ID: 21694720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation mechanisms of the E3 ubiquitin ligase parkin.
    Panicker N; Dawson VL; Dawson TM
    Biochem J; 2017 Aug; 474(18):3075-3086. PubMed ID: 28860335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Policing Parkin with a UblD.
    Liu F; Walters KJ
    EMBO J; 2011 Jul; 30(14):2757-8. PubMed ID: 21772326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.
    Yao D; Gu Z; Nakamura T; Shi ZQ; Ma Y; Gaston B; Palmer LA; Rockenstein EM; Zhang Z; Masliah E; Uehara T; Lipton SA
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10810-4. PubMed ID: 15252205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive computational study on pathogenic mis-sense mutations spanning the RING2 and REP domains of Parkin protein.
    Biswas R; Bagchi A
    Gene; 2017 Apr; 610():49-58. PubMed ID: 28189762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkin Somatic Mutations Link Melanoma and Parkinson's Disease.
    Levin L; Srour S; Gartner J; Kapitansky O; Qutob N; Dror S; Golan T; Dayan R; Brener R; Ziv T; Khaled M; Schueler-Furman O; Samuels Y; Levy C
    J Genet Genomics; 2016 Jun; 43(6):369-79. PubMed ID: 27297116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
    Sriram SR; Li X; Ko HS; Chung KK; Wong E; Lim KL; Dawson VL; Dawson TM
    Hum Mol Genet; 2005 Sep; 14(17):2571-86. PubMed ID: 16049031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease-associated protein Parkin: an unusual player in cancer.
    Liu J; Zhang C; Hu W; Feng Z
    Cancer Commun (Lond); 2018 Jun; 38(1):40. PubMed ID: 29941042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parkin protein and molecular mechanism of Parkinson's disease].
    Imai Y
    Nihon Ronen Igakkai Zasshi; 2004 Nov; 41(6):619-21. PubMed ID: 15651375
    [No Abstract]   [Full Text] [Related]  

  • 12. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function.
    Chung KK; Thomas B; Li X; Pletnikova O; Troncoso JC; Marsh L; Dawson VL; Dawson TM
    Science; 2004 May; 304(5675):1328-31. PubMed ID: 15105460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-protein ligase parkin and its role in the development of Parkinson's disease.
    Buneeva OA; Medvedev AE
    Biochemistry (Mosc); 2006 Aug; 71(8):851-60. PubMed ID: 16978147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospho-ubiquitin: upending the PINK-Parkin-ubiquitin cascade.
    Matsuda N
    J Biochem; 2016 Apr; 159(4):379-85. PubMed ID: 26839319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenetic mechanisms of parkin in Parkinson's disease.
    Hattori N; Mizuno Y
    Lancet; 2004 Aug 21-27; 364(9435):722-4. PubMed ID: 15325839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin: much more than a simple ubiquitin ligase.
    Alves da Costa C; Checler F
    Neurodegener Dis; 2012; 10(1-4):49-51. PubMed ID: 22204976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel parkin-mediated transcriptional function links p53 to familial Parkinson's disease.
    da Costa CA; Checler F
    Cell Cycle; 2010 Jan; 9(1):16-7. PubMed ID: 20016267
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mechanisms underling the cause of Parkinson's disease: the functions of Parkin/PINK1].
    Tanaka K; Matsuda N; Okatsu K
    Rinsho Shinkeigaku; 2010 Nov; 50(11):867. PubMed ID: 21921477
    [No Abstract]   [Full Text] [Related]  

  • 19. How do Parkin mutations result in neurodegeneration?
    Imai Y; Takahashi R
    Curr Opin Neurobiol; 2004 Jun; 14(3):384-9. PubMed ID: 15194120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that phosphorylated ubiquitin signaling is involved in the etiology of Parkinson's disease.
    Shiba-Fukushima K; Ishikawa KI; Inoshita T; Izawa N; Takanashi M; Sato S; Onodera O; Akamatsu W; Okano H; Imai Y; Hattori N
    Hum Mol Genet; 2017 Aug; 26(16):3172-3185. PubMed ID: 28541509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.